Edge Endo LLC
$113.4M 40 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Sanofi US Services Inc.
Sanofi US Services Inc. reported $113,981,413.64 across General Payments, Research, and Ownership to 478 physicians and teaching hospitals across 11,016 transactions.
- $114.0M
- All-tracks total
- 11,016
- Transactions
- 478
- Recipients
- +$80.8K
- General Payments vs PY2023
Sanofi US Services Inc. reported $113,981,413.64 across all CMS Open Payments tracks (General + Research + Ownership) to 478 physicians and teaching hospitals in Program Year 2024 - ranking #21 of 1,925 reporting manufacturers (0.8% of the all-tracks industry total); General Payments alone were $1,185,642.92, averaging $238.5K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer sanofi-us-services-inc Sanofi US Services Inc.
$114.0M · #21/1,925 · 0.8% industry · PY2024
- TOT $114.0M
- RANK #21
- SHARE 0.8%
- TXN 11,016
- RCP 478
- CAT 7
- GEN $1.2M
- ΔGEN +$80.8K
- TOP1 21.1%
- PY 2024
Volume peers
Nearest volume peer: Edge Endo LLC ($113.4M)
Sanofi US Services Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Sanofi US Services Inc.'s CMS-reported General Payments increased by $80.8K (+7.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SANOFI US SERVICES INC.PY2023: SANOFI US SERVICES INC.PY2024: SANOFI US SERVICES INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,104,887.31
- PY2024
- $1,185,642.92
What the Data Shows for Sanofi US Services Inc.
Rank #21 of 1,925 companies in CMS Open Payments for 2024 belongs to Sanofi US Services Inc., which reported $113,981,413.64 across 11,016 transactions to 478 recipients - representing 0.8% of all industry payments reported nationwide for the year. Averages work out to $10.3K per transaction and $238.5K per recipient.
"Consulting Fee" leads the 7-category general-payment breakdown below at $516.6K (43.6% of General Payments, 175 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 7 types of general payments, Sanofi US Services Inc.'s largest category was "Consulting Fee" at $516.6K - 43.6% of General Payments.
Sanofi US Services Inc. reports 7 general-payment categories - the top three are Consulting Fee (43.6%), Compensation for Services Other Than Consulting (35.0%), and Charitable Contribution (12.3%). The remaining 4 categories make up 9.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Sanofi US Services Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $516.6K | 175 | 43.6% |
| Compensation for Services Other Than Consulting | $414.6K | 26 | 35.0% |
| Charitable Contribution | $145.5K | 71 | 12.3% |
| Grant | $58.6K | 20 | 4.9% |
| Royalty or License | $38.2K | 5 | 3.2% |
| Travel and Lodging | $8.0K | 11 | 0.7% |
| Food and Beverage | $4.1K | 170 | 0.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $477,941.99 (40.3%) of $1,185,642.92 in this company's General Payments records across 307 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sanofi US Services Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Tufts Medical Center
$250,000.00 across 1 reported transactions
- 2
Brigham And Womens Hospital
$110,124.56 across 12 reported transactions
- 3
Univ Of Mi Hospitals & Hlth Ctrs
$62,315.43 across 6 reported transactions
- 4
Stephen Pappas
$28,858.00 across 5 reported transactions
- 5
Dana-Farber Cancer Institute
$26,644.00 across 37 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Sanofi US Services Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Sanofi US Services Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Sanofi US Services Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Trimed, Inc.
$111.0M 2,318 recipients
Compare payment profiles
Vertex Pharmaceuticals Incorporated
$109.6M 10,996 recipients
Compare payment profiles
Arthrex, Inc.
$109.0M 49,842 recipients
Compare payment profiles
Regeneron Pharmaceuticals, Inc.
$123.5M 5,932 recipients
Compare payment profiles
AstraZeneca UK Limited
$124.7M 2,367 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.